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Abstract
Candida parapsilosis is a pathogenic fungus that is major cause of hospital-acquired infection, predominantly due to growth
as biofilms on indwelling medical devices. It is related to Candida albicans, which remains the most common cause of
candidiasis disease in humans. The transcription factor Bcr1 is an important regulator of biofilm formation in vitro in both C.
parapsilosis and C. albicans. We show here that C. parapsilosis Bcr1 is required for in vivo biofilm development in a rat
catheter model, like C. albicans. By comparing the transcription profiles of a bcr1 deletion in both species we found that
regulation of expression of the CFEM family is conserved. In C. albicans, three of the five CFEM cell wall proteins (Rbt5, Pga7
and Csa1) are associated with both biofilm formation and acquisition of iron from heme, which is an important virulence
characteristic. In C. parapsilosis, the CFEM family has undergone an expansion to 7 members. Expression of three genes
(CFEM2, CFEM3, and CFEM6) is dependent on Bcr1, and is induced in low iron conditions. All three are involved in the
acquisition of iron from heme. However, deletion of the three CFEM genes has no effect on biofilm formation in C.
parapsilosis. Our data suggest that the role of the CFEM family in iron acquisition is conserved between C. albicans and C.
parapsilosis, but their role in biofilm formation is not.
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Introduction
Candida species are among the most common causes of
nosocomial bloodstream infection, and have associated mortality
rates ranging from 28–59% [1,2]. Candida albicans is still the most
commonly isolated, but other Candida species such as C. glabrata, C.
parapsilosis and C. krusei are increasingly reported [1,2,3]. C.
parapsilosis in particular is found on the hands of health care
workers, and has been responsible for several outbreaks of
infection [4,5,6,7,8].
Although often found as commensal organisms with humans,
Candida species are also capable of growth as antifungal-resistant
biofilms on non-biological surfaces such as medical equipment.
Surgical intervention and the increasingly invasive nature of
medical care, supported by the use of catheters or intravenous
devices, provide opportunities for the dissemination of these
biofilm-forming fungi [9]. Whereas all Candida species form
biofilms on solid surfaces, the structures are highly variable
[10,11]. In C. albicans, biofilms are multilayered and contain yeast
cells, pseudohyphae and hyphae [12]. Biofilm development by C.
albicans has been well characterized, and occurs in several stages
(reviewed in [10,13]). Adherence of yeast cells to the substrate is
followed by an intermediate stage where hyphae are formed and
an extracellular matrix is generated. A mature biofilm consists of
densely packed hyphae and yeast cells surrounded by the
extracellular matrix, consisting mostly of polysaccharides [14]. C.
parapsilosis biofilms in contrast consist of a dense network of yeast
cells and pseudohyphae, but they also contain large amounts of
carbohydrate [11,15].
BCR1 (Biofilm and Cell wall Regulator 1) is a conserved fungal
transcription factor required for biofilm formation in both C.
albicans and C. parapsilosis [16,17,18]. Some major targets of Bcr1
in C. albicans include genes that encode for adhesins and cell-wall
proteins (ALS1, ALS3, HWP1, and RBT5 and related genes),
suggesting that Bcr1 is involved in the early adhesion stage of
biofilm development [17,18,19,20]. Although the C. parapsilosis
genome contains members of all these gene families, there are
substantial differences between the species [21]. For example,
ALS3, a major adhesin, is found only in C. albicans, and not in other
Candida species [22]. Rbt5 is a member of the CFEM (common in
fungal extracellular membranes) family of proteins with an eight-
cysteine domain resembling an EGF domain, which was originally
identified in Magnaporthe grisea [23,24]. Many family members
contain putative GPI-anchors, and several are identified with
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lular regions of membrane proteins, and Kulkarni et al [23]
suggested that CFEM proteins may act as cell surface receptors or
as adhesins. There are five members of the CFEM family in C.
albicans, of which at least three (RBT5, PGA10 and CSA1) are
important for biofilm development [25]. In C. parapsilosis the family
has undergone an expansion to seven members, which includes
tandem duplicates of orthologs of C. albicans RBT5, PGA10 and
CSA1.
The ability to acquire essential iron from host proteins is
critical for survival of pathogenic fungi. Iron is generally a
limiting nutrient, and is often sequestered by the host [26]. C.
albicans has multiple mechanisms for utilizing iron sources from
the environment, including a reductive pathway and transport of
heterologous siderophores (reviewed in [27]). Some Bcr1 targets
in C. albicans also play a role in acquiring iron from host proteins.
These include two CFEM proteins, Rbt5 and Pga10, which act as
receptors for hemoglobin, allowing endocytosis of the host iron
complex [28,29]. Als3, uniquely among the ALS family of
adhesins, binds to ferritin, enabling its use as a source of iron
[30].
We describe here an analysis of the role of Bcr1 in C. parapsilosis.
We show for the first time that C. parapsilosis generates biofilms in
vivo in a rat catheter model, and that BCR1 is required for this
process. Whereas there is little overlap among the targets of Bcr1
in the two species, regulation of the CFEM family is conserved.
Moreover, the role of CFEM proteins in iron acquisition is
conserved. However, unlike C. albicans, the CFEM genes are not
required for biofilm formation in C. parapsilosis.
Results
BCR1 is required for in vivo biofilm formation in C.
parapsilosis
To date, most investigations of biofilm development by C.
parapsilosis have used in vitro systems, such as growth in 96-well
plates or on silicon squares [16,31,32,33,34]. However, in C.
albicans, mutants do not always behave the same in in vitro and in
vivo models. For example, deleting ALS3 has a dramatic effect on
biofilm development in vitro, but not in vivo [17]. We therefore
tested the ability of C. parapsilosis to grow as biofilms in the rat
catheter model, designed for investigating C. albicans biofilm
development [35]. Figure 1 shows that C. parapsilosis wildtype cells
produce a robust biofilm 24 h after the introduction of cells into
the catheter. Although the structure differs from C. albicans biofilms
in that there are no hyphae present, a thick biofilm layer is formed.
In contrast, strains carrying a deletion of BCR1 [16] form a very
thin and sparse layer of cells (Figure 1), showing that BCR1 is also
required for biofilm formation in vivo as well as in vitro [16]. These
experiments illustrate the robustness of the rat catheter biofilm
model, and demonstrate that it can be extended to species that do
not generate hyphae.
Figure 1. BCR1 is required for C. parapsilosis biofilm formation in vivo. Central venous catheters were introduced into rats and inoculated with
C. parapsilosis wildtype (CLIB214) or bcr1 deletion (CDb71) strains. Following initial adhesion, the cells were flushed and locked with heparinized
0.85% NaCl. The catheters were removed after 24 h and visualized at two magnifications by SEM.
doi:10.1371/journal.pone.0028151.g001
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We previously described the construction of a bcr1 knockout in
C. parapsilosis using a nourseothricin-resistant SAT1-flipper cassette,
which can be recycled and reused to disrupt multiple alleles [16].
However, the method is relatively slow and reintroducing the
BCR1 gene did not fully reconstitute the phenotype [16]. To
facilitate the identification of targets, we generated a second bcr1
deletion using a different method. Firstly, the HIS1 gene was
deleted in a ura3 auxotrophic background [16] using the SAT1-
flipper cassette (Figure S1A). The two BCR1 alleles were then
disrupted in this ura3D his1D background by replacing one allele
with URA3 and the other with HIS1 (Figure S1B). The
bcr1D::FRT/bcr1D::FRT strain (CDb71) described previously [16]
and the bcr1D::URA3/bcr1D::HIS1 strain (CDUHB6) were grown
in biofilm inducing conditions (SD, 50 mM glucose, and 10% FBS
at 37uC), and used for expression profiling as described in
Rossignol et al [36]. The data from both knockouts were
considered together to remove any artifacts associated with the
individual knockouts, such as strain-specific effects that are
unrelated to Bcr1. We also determined the transcriptional profile
of C. albicans BCR1/BCR1 and bcr1D/bcr1D strains (DAY286 and
CJN702, respectively, gifts from A. Mitchell) grown in the same
conditions, to facilitate a comparison of the two species. We
included the data from transcriptional profiling of the C. albicans
bcr1 deletion strain grown in Spider media previously reported by
Nobile and Mitchell [18].
Somewhat surprisingly, there is very little overlap between the
targets of Bcr1 in C. albicans and C. parapsilosis (Figure 2A). Only
four genes are present in the intersection of the three data sets, and
one is BCR1, which is deleted in all strains. However, one notable
observation is that RBT5, a member of the CFEM family, is also
present in the intersection of the three data sets. Of the remaining
two genes in the intersection, one (orf19.716) is differently
regulated in C. albicans and C. parapsilosis, and the other (DAG7)
has increased expression in both species. Expression of these genes
was not investigated further.
There are five members of the CFEM family in C. albicans
(PGA7, PGA10, RBT5, CSA1 and CSA2) and seven members in C.
parapsilosis, which we have named CFEM1-CFEM7. Four of these
(CFEM1-4) are tandemly arranged, and are syntenic with RBT5
and PGA7 (Figure 2B). Other Candida clade species contain only
two genes in this region. Examination of synteny, together with
phylogenetic analysis, suggests that both RBT5 and PGA7 have
undergone single gene duplications in C. parapsilosis, leading to the
formation of CFEM1/CFEM2 and CFEM3/CFEM4, respectively.
Similarly, CFEM5 and CFEM6 are orthologous with CSA1 (not
shown). However, CFEM7 has no observable ortholog within the
Candida clade (not shown) and may represent a relatively recent
evolutionary addition to the CFEM family specific to C. parapsilosis.
Because the CFEM genes are not directly orthologous in the
two species, we used qRT-PCR to determine the role of Bcr1 in
regulating expression of most of the related family members in
both (Figure 2C). Firstly, we showed that expression of three family
members (RBT5, PGA7 and CSA1) is reduced in C. albicans bcr1D,
which confirms and extends some previously published observa-
tions [18]. One member of each orthologous pair in C. parapsilosis,
CFEM2, CFEM3 and CFEM6, is downregulated in the bcr1D
mutant (Figure 2C and Table S1). In contrast, expression of
CFEM1, CFEM4, CFEM5, and CFEM7 is essentially unchanged.
Figure 2. Bcr1 regulates expression of CFEM genes in C.
parapsilosis and C. albicans. A. Intersection between the targets of
Bcr1 in C. albicans and C. parapsilosis. The data from C. albicans cells
grown in Spider media is taken from Nobile and Mitchell [18]. The lists
of genes regulated in both species grown in SD+FBS media is provided
in Table S1 and Table S2. B. Gene order around the CFEM genes in
seven yeast species (adapted from the Candida Gene Order Browser,
[69]). The order of HIS4, RBT5, PGA7 and FRP1 is highly conserved across
most Candida species. In C. parapsilosis, however, RBT5 and PGA7 have
undergone gene duplication, resulting in four adjacent genes, named
CFEM1, CFEM2, CFEM3 and CFEM4. CFEM5 and CFEM6 are also adjacent
to each other elsewhere in the genome (not shown). Thick black lines
represent adjacent genes. Two thin black lines represent a gap of less
than 5 genes, and one thin line represents a gap of less than 20 genes.
A black line with breaks indicates genes that are not on the same
chromosomes. Ca: C. albicans; Cd: Candida dubliniensis; Ct: Candida
tropicalis;C p :C. parapsilosis;L e :Lodderomyces elongisporus;D h :
Debaryomyces hansenii; Cl: Candida lusitaniae. C. Expression of CFEM
members (CFEM1 to CFEM7)i nC. parapsilosis and the homologous
genes in C. albicans was determined using qRT-PCR. All strains were
grown in SD medium supplemented with 50 mM glucose and 10% FBS
for 5 h at 37uC.
doi:10.1371/journal.pone.0028151.g002
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transcription factor Bcr1 is conserved between C. albicans and C.
parapsilosis, but not all members of the family are regulated by Bcr1
in C. parapsilosis.
Deletions of CFEM genes do not affect biofilm formation
in C. parapsilosis
Deletion of BCR1 in either C. albicans or C. parapsilosis results in
an inability to form biofilms (Figure 1, [16,18]. In addition,
deleting RBT5, PGA10 or CSA1 in C. albicans also reduces biofilm
development [25]. This suggests that the role of Bcr1 in regulating
biofilm development is partially effected through controlling
expression of the CFEM family. We therefore tested the role of
the Bcr1-regulated members of the CFEM family in C. parapsilosis
on biofilm development. CFEM2 and CFEM3 were deleted
simultaneously by replacement with URA3 and HIS1 as they are
adjacent in the genome, and the wildtype genes were subsequently
individually re-introduced using the SAT1 flipper cassette. CFEM6
was deleted separately (Figure 3).
We determined the ability of the cfem2D/cfem3D and cfem6D
strains to form biofilms on microtiter plates and on silicone
squares. Surprisingly, neither deletion had a measurable effect on
biofilm mass or structure, as ascertained by crystal violet staining
of the microtiter plates (Figure 3D) and confocal microscopy of the
Figure 3. C. parapsilosis CFEM genes are not required for biofilm formation. A. C. parapsilosis CFEM2 and CFEM3 were deleted simultaneously
by replacement with CaURA3 and CaHIS1 to generate a homozygous cfem2D/cfem3D strain (CDUH25/26). Complemented strains contain either
CFEM2 or CFEM3, re-introduced by using the SAT1-flipper cassette at the cfem2D/cfem3D::HIS1 locus. B. The homozygous cfem6D strains were
generated by two methods. (i) Strain CD74UH1 was made by replacing each CFEM6 allele with CaURA3 and CaHIS1. (ii) Strain CD749 was created by
two rounds of CFEM6 gene deletion with the recyclable SAT1-flipper. C. (i) The construction of the cfem2D/cfem3D homozygous (CDUH25/26) and
CFEM2 and CFEM3 complemented strains (CD252 and CDC262, respectively) was confirmed by Southern blot using a probe hybridizing to promoter
sequence from CFEM3. The expected sizes are described in Materials and Methods. Lane 1: CLIB214 (C. parapsilosis wildtype strain); lane 2:
CDUH2526his (CFEM2+3/cfem2+3D::HIS1); lane 3: CDUH25/26 (cfem2+3D::URA3/cfem2+3D::HIS1); lane 4: CD26 (cfem2D+CFEM3::SAT1-FLP/cfem2+3-
D::URA3); lane 5: CD262 (cfem2D+CFEM3::FRT/cfem2+3D::URA3); lane 6: CD25 (CFEM2D+cfem3::SAT1-FLP/cfem2+cfem3D::URA3); lane 7: CD254
(CFEM2+cfem3D::FRT/cfem2+3D::URA3). (ii) The construction of CFEM6 was confirmed by Southern blot using a probe hybridizing to sequence from
the 39 end of CFEM6. Lane 1: CLIB214 (C. parapsilosis wildtype strain); lane 2: CD74U2 (CFEM6/cfem6D::URA3); lane 3:CD74UH1 (cfem6D::HIS1/
cfem6D::URA3); lane 4: CD741 (cfem6D::SAT1-FLP/CFEM6); lane 5: CD745 (cfem6D::FRT/CFEM6); lane 6: CD746 (cfem6D::FRT/cfem6D::SAT1-FLP); lane
7:CD749 (cfem6D::FRT/cfem6D::FRT). D. Biofilms formed by C. parapsilosis CLIB214 (wildtype), CDUH25/26 (cfem2D/cfem3D), CD74UH1 (cfem6D::URA3/
cfem6D::HIS1), and CD749 (cfem6D::FRT/cfem6D::FRT) were measured in 96-well plates as previously described [31]. Biofilms were stained using crystal
violent and the A570 was measured. Three biological replicates used, each replicated eight times on the same plate. E. Biofilms grown on silicon
squares by C. parapsilosis were visualized using confocal microscopy as previously described [16]. The structure of biofilm matrix was obtained using
a4 0 6lens, and the depth of biofilm was measured using a 106lens. The depth of the biofilm in C. parapsilosis strains ranges from 90 to 120 mm. The
depths for the individual strains are approximately 116 mm in CLIB214; 120 mm in CDUh25/26; 98 mm in CD74UH1; and 96 mm in CD749.
doi:10.1371/journal.pone.0028151.g003
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CFEM2, CFEM3 nor CFEM6 are required for biofilm growth in C.
parapsilosis. However, the possibility remains that other CFEM
genes may compensate for this function in the cfem2D/cfem3D and
cfem6D mutants.
Role of the CFEM family in iron acquisition in C.
parapsilosis
Many species, including C. albicans and S. cerevisiae, induce
multiple pathways for iron acquisition during growth in iron-
depleted media [27,37]. In C. albicans, the CFEM proteins Rbt5
and Pga10 are required specifically for heme-iron utilization
[28,29]. We first tested if Bcr1, as a regulator of CFEM expression,
is also involved in iron acquisition. We plated strains on rich, iron-
depleted (BPS), or hemin-supplemented BPS plates. Both C.
albicans and C. parapsilosis grow very poorly under iron-depleted
conditions (Figure 4A). Growth of both species is rescued by the
addition of hemin, although C. parapsilosis is better able to utilize
hemin as a sole iron source than C. albicans. C. albicans bcr1D
colonies are smaller than wildtype colonies grown for an
equivalent time on hemin plates (Figure 4A), suggesting that
Bcr1 may contribute to the regulation of heme utilization in this
species. In contrast, the absence of BCR1 has no obvious effect on
heme utilization in C. parapsilosis (Figure 4A).
To test if the CFEM genes in C parapsilosis play any role in
acquisition of iron from heme, we plated dilutions of cfem2D/
cfem3D and cfem6D strains on iron-depleted (BPS) or hemin-
supplemented (BPS+hemin) plates (Figure 4B). The homozygous
cfem2D/cfem3D strain can no longer grow on plates containing
hemin as a sole source of iron. Reintroducing a single copy of
CFEM2 alone does not significantly restore growth, but reintro-
ducing CFEM3 partially restores growth (Figure 4B). However, it
appears that both CFEM2 and CFEM3 (or perhaps two alleles of
either) are required to obtain wildtype levels of growth (compare
the reconstituted strains with the heterozygote). Deleting CFEM6
also reduces growth on hemin, although the effect is not as
dramatic as in the cfem2D/cfem3D homozygous knockout
(Figure 4B). Thus, CFEM6 is partially required while CFEM2
and CFEM3 are vital for heme utilization in C. parapsilosis.
Iron-depletion induces CFEM gene expression in C.
parapsilosis
We used qRT-PCR to further examine the effect of iron
depletion on expression of the CFEM family in C. parapsilosis. Cells
were grown in the presence of the iron chelator BPS, and in the
absence of serum (FBS) which we induces expression of the CFEM
family (not shown). Expression of CFEM2, CFEM3, CFEM4 and
CFEM6 is induced when iron levels are low, and expression is
reduced when hemin is added (Figure 4C). Induction of expression
in low iron requires Bcr1. Expression of CFEM1, CFEM5 and
CFEM7 is not reproducibly induced by iron depletion (Figure 4C)
and is not regulated by Bcr1 (Figure 2C). The expression data
suggests that CFEM4 may also play a role in iron acquisition from
heme, which we have not tested.
To determine how important the CFEM family is for iron
acquisition in C. parapsilosis, we determined the global transcrip-
tional profile of cells grown in iron-depleted conditions. We
identified 59 genes with increased expression, and 89 genes with
decreased expression (Table S3). As expected, we observed
significant increases in expression of genes associated with cellular
iron ion homeostasis and iron ion transport, such as FTH1, FRE9,
and FRE10 (Table 1, Table S3). In contrast, expression of heme-
containing and iron-sulfur proteins (e.g. YHB1, SDH2, ISA1) and of
all mitochondrial genes is reduced (Table S3). Overall the response
of C. parapsilosis and C. albicans to low iron conditions is very similar
[38,39]. Three of the CFEM family (CFEM2, CFEM3 and
CFEM6) are among the genes with the highest increases in
expression (logFC.1.9), confirming that they play an important
role in the iron response (Table 1).
Discussion
Both biofilm formation and iron acquisition are contributing
factors to the pathogenicity of Candida species. Our analysis shows
that the Bcr1 transcription factor is an important regulator of
biofilm development in vitro and in vivo in the two species, and that
regulation of expression of some members of the CFEM family is
conserved [16,17,18]. However, the Bcr1-dependent CFEM genes
do not play a role in biofilm development in C. parapsilosis.
Transcriptional profiling reveals that RBT5/CFEM2 is regulat-
ed by Bcr1 in both C. albicans and C. parapsilosis, and follow-up
analysis confirmed that several members of the CFEM family are
regulated in the two species. There is very little other overlap
between the targets of Bcr1 (Figure 2C, Tables S1 and S2). Both
species were grown in conditions that promote biofilm production
in C. parapsilosis (SD+10% FBS at 37uC) [16]. However, these
conditions are also ideal for hyphal growth by C. albicans.W e
included published data from transcriptional profiling of a C.
albicans bcr1 deletion grown in Spider media, which also induces
hyphal growth [18]. Several genes associated with both biofilm
development and with hyphal growth (including members of the
CFEM family) are differentially expressed in the two experiments.
Four genes have altered expression in C. albicans bcr1 irrespective of
growth conditions (ALS3, ECE1, PTP3 and CFL2). None of these
have direct orthologs in C. parapsilosis, although apart from PTP3,
they are all members of gene families that are represented in the
two species. The first three genes are induced in hyphae in C.
albicans [40,41,42]. It is therefore likely that in C. albicans, Bcr1
plays a role in regulating expression of hyphal-induced genes that
is not conserved in C. parapsilosis.
There are ten genes that are differentially expressed in both C.
albicans and C. parapsilosis grown in the same conditions (SD+10%
FBS). However, many of these have reduced expression in C.
albicans and increased expression in C. parapsilosis (Table S4), and
are therefore unlikely to form part of the conserved Bcr1 regulon.
In C. albicans, expression of the CFEM genes RBT5, PGA7, and
to a lesser extent CSA1, is dependent on Bcr1 (Fig. 2C). In C.
parapsilosis, each of these genes has been duplicated, generating
CFEM1 to CFEM6; CFEM1 to CFEM4 are found in tandem, and
CFEM5 and CFEM6 are also adjacent but a different location to
the other four. The final member of the C. parapsilosis family,
CFEM7, does not have a syntenic ortholog in C. albicans. Within
the three gene pairs, expression of one (CFEM2, CFEM3 and
CFEM6) is highly dependent on Bcr1, whereas expression of the
other member of the pair is reduced only slightly, if at all, in a bcr1
deletion. In fact, expression of CFEM5 may be repressed (Fig. 2C).
This suggests that following the gene duplication event(s), one copy
of each pair retained the Bcr1-dependent regulation, which was
lost in the second copy. It is not yet clear what the biological
significance of the gene duplication events is or why the regulation
by Bcr1 is different.
CFEM genes in C. albicans play an important role in the
acquisition of iron from host proteins [28,29]. Expression of RBT5
is highly induced under low iron conditions [28,38,39] and the
protein binds heme and is required for endocytosis of hemoglobin
[28,29]. Deleting PGA10 (also known as RBT51) has no obvious
affect on growth on heme, but when introduced into S. cerevisiae it
Bcr1 and CFEM Proteins in Candida Species
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e28151Figure 4. CFEM2, CFEM3, and CFEM6 are required for heme utilization. A. C. parapsilosis strains CLIB214 (wild-type), CDb71 (bcr1D::FRT/
bcr1D::FRT) and CDUHB6 (bcr1D::HIS1/bcr1D::URA3) and C. albicans strains SC5314 (wild-type) and CJN702 (bcr1D) were serially diluted on YPD plates,
YPD supplemented with 1 mM BPS, and YPD supplemented with 1 mM BPS and 2 mM hemin for 7 days at 30uC. Deleting BCR1 in C. albicans reduces
colony size, which is shown by photographing individual colonies on YPD plates supplemented with 1 mM BPS and 2 mM hemin after 7 days. Pictures
were taken on the same day and magnification. B. C. parapsilosis strains containing deletions of CFEM genes were serially diluted on plates as
described in (A) and were incubated at 30uC for two days (YPD plates) or 14 days (BPS+/2hemin) before photographing. Strains shown in the
following order: CLIB214, CDUH25/26, CDUH254, CDUH262, CDUH25/26 his, CD748, CD743. C. Expression of C. parapsilosis CFEM genes was
determined using qRT-PCR. RNA was extracted from CLIB214 and CDb71 cells grown in SD+50 mM glucose with no BPS, 200 mM BPS, and 200 mM
BPS supplemented with 2 mM hemin for 5 h at 37uC (p values:*,0.05).
doi:10.1371/journal.pone.0028151.g004
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[28]. CSA1 is also required for maximal binding of heme [28]. We
used RT-PCR to test the response of the entire CFEM family in C.
parapsilosis to low iron conditions, and showed that expression of
CFEM2, CFEM3, CFEM4, and CFEM6 are greatly induced. The
iron-dependent response was partially alleviated by adding back
hemin. Bcr1 regulates these genes, apart from CFEM4, in the
presence of serum (Figure 2C) and induction of expression of all
four in iron-depleted conditions is dependent on Bcr1 (Figure 4).
We therefore tested the role of Bcr1 in iron acquisition. However,
deleting bcr1 has no obvious effect on cell growth on hemin as a
sole iron source, whereas CFEM2, CFEM3 and to a lesser degree
CFEM6 are clearly required. The basal level of expression of the
CFEM family in the absence if BCR1 is therefore sufficient for
survival of C. parapsilosis on hemin. In C. albicans, Bcr1 may be
more important for iron utilization because a deletion grows slowly
when heme is the only source of iron present (Figure 4A), although
the reduction of growth is not as dramatic as when the RBT5 is
deleted [28]. The role of the CFEM family in iron acquisition is
therefore conserved between C. albicans and C. parapsilosis, and is
likely to be an ancestral feature of the Candida clade.
We used global transcriptional profiling to investigate the role of
the CFEM family in the response to iron. Our analysis confirmed
the large levels of induction of CFEM2, CFEM3 and CFEM6,
which lie among the 20 genes with the greatest increases in
expression (Table 1, Table S3). We did not identify increases in
CFEM4, detected by RT-PCR (Figure 4C). Further analysis of the
microarray data indicates that iron-dependent expression in C.
parapsilosis is similar to C. albicans [38,39]. When iron is depleted,
expression of components of the reductive transport system (e.g.
FRE9, FRE10, and several other potential ferric reductases) is
increased (Table 1). Expression of heme oxygenase is also
increased, whereas expression of many respiratory protein genes
is reduced. It is likely that at least some of the same transcription
factors control the transcriptional response to iron in both species,
because an ortholog of SFU1 (a GATA-type repressor of
transcription in C. albicans in high iron conditions [38] and of
HAP43 (a member of the CCAAT-binding complex, an iron-
dependent repressor in C. albicans [43,44], is reduced. Expression
of SEF1, which was recently shown to be an activator of iron-
uptake genes in C. albicans [39] is increased (Table 1, Table S3).
The regulatory circuit described for Sfu1, Sef1 and Hap43 in C.
albicans [39] is therefore also likely to function in C. parapsilosis.I n
C. albicans, expression of several of the CFEM genes is directly
controlled by Sef1, and some are also regulated by Sfu1 [39]. It is
highly likely that these factors are also required for the iron-
dependent expression of CFEM2, CFEM3, CFEM4 and CFEM6
that we observed in C. parapsilosis.
Expression of CPAG_02488, the sole C. parapsilosis homolog of
the S. cerevisiae CTH1/CTH2 genes, is induced in low iron (Table 1).
In S. cerevisiae these genes encode RNA binding proteins that
control the degradation of mitochondrial-associated mRNAs in
response to iron levels [45,46,47]. It is therefore likely that the
iron-response in Candida species is also regulated by post-
translational mechanisms, similar to S. cerevisiae.
In C. albicans, deleting RBT5, PGA10 or CSA1 does not have any
effect on very early stage biofilms, but by 8 h a defect is obvious
[25]. The biofilms generated were very fragile, and detached easily
from the surface. Deleting all three genes resulted in more severe
defects. The fragile biofilms generated resemble those produced by
bcr1 knockouts in C. albicans [17,18]. Because Bcr1 regulates
biofilms in both C. albicans and C. parapsilosis and also controls
expression of CFEM genes in both species, we expected that the
CFEM family in C. parapsilosis would play a role in biofilm growth
in this species. We were therefore surprised that the three CFEM
knockouts we generated in C. parapsilosis have no effect on biofilms
(Figure 3). There are 7 members of the CFEM family in C.
parapsilosis, and although we tested the major targets of Bcr1
(Figure 2C) it is possible that other family members are required
for biofilm growth. However, there is clearly a difference in the
behavior of the CFEM deletions in biofilm growth in the two
species. We also find that the biofilm defects in the BCR1 deletions
in the two species are not identical. The C. albicans knockout
generates biofilms that are very fragile and easily washed off the
substrate, whereas there is little evidence for any biofilm formation
at all in the C. parapsilosis bcr1 knockout [16]. Yi et al [48] have
recently demonstrated that in C. albicans, Bcr1-dependent biofilm
formation is also affected by mating type. Whereas Bcr1 is
required for biofilm formation by a/alpha cells, it does not play a
role in biofilms generated by a/a cells. All the C. parapsilosis
biofilms described here are generated by a/a cells, and it is very
likely that this species has only MTLa idiomorphs [49,50]. It is
therefore likely that Bcr1 has a species-specific role in biofilm
formation.
The ortholog of Bcr1 in S. cerevisiae is Usv1which regulates genes
involved in non-fermentative growth and salt stress [51], and has
been predicted to regulate genes important for protein folding
during stationary phase [52]. This is substantially different to the
Table 1. Selected C. parapsilosis genes differentially
expressed in low iron conditions.
C. parapsilosis
gene name
1 C. parapsilosis ID
2 C. albicans homolog Log FC
CFEM family
CFEM2 CPAR2_402910 RBT5 3.49
CFEM3 CPAR2_402900 PGA10 2.92
CFEM6 CPAR2_300120 CSA1 1.96
Reductive iron transport
CPAG_00389 CPAR2_300630 orf19.7077 (FRE7-like) 4.92
CPAG_00390 CPAR2_300620 orf19.7077 (FRE7-like) 3.68
CPAG_00393 CPAR2_300580 orf19.7077 (FRE7-like) 3.65
CPAG_03224 CPAR2_805630 FTR1-like 3.11
CPAG_03730 CPAR2_603590 FET99 2.62
CPAG_03065 CPAR2_210140 FRE9 2.35
CPAG_01229 CPAR2_210100 FTH1 2.55
CPAG_03792 CPAR2_602990 CTR1 2.25
CPAG_04019 CPAR2_401740 FRE10 0.96
CPAG_03370 CPAR2_303120 CCC2 0.91
CPAG_00623 CPAR2_300130 FRP2 0.69
Other iron transporters
CPAG_03610 CPAR2_105690 HMX1 0.81
Transcription factors/regulatory proteins
CPAG_02488 CPAR2_407950 CTH1 (orf19.5334) 1.61
CPAG_04485 CPAR2_801430 SEF1 0.94
CPAG_01899 CPAR2_209090 HAP43 0.84
CPAG_03938 CPAR2_301500 MAC1 0.75
CPAG_04289 CPAR2_700810 SFU1 21.09
1C. parapsilosis ID from http://www.broadinstitute.org/annotation/genome/
candida_group/MultiHome.html.
2C. parapsilosis ID from accession no. HE605202-HE605210.
doi:10.1371/journal.pone.0028151.t001
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study changes in Bcr1 function within Candida species, it will be
necessary to identify the binding sites in the promoters of target
genes. Many Bcr1-regulated genes in C. albicans are controlled by
several proteins. For example, expression of RBT5 is repressed by
Tup1, Hog1 and Sfu1, and induced by Rfg1 and Rim101
[38,53,54,55,56]. Identification of the direct target sites of Bcr1 in
each species will therefore require direct analysis of bound genes.
Comparative genomic analysis is an important predictor of gene
function. Comparisons between S. cerevisiae and C. albicans have
been very helpful in the study of transcriptional regulation, such as
dissecting the roles of Gat1, a regulator of nitrogen utilization in
both species [57], and Upc2, which controls expression of
ergosterol biosynthesis genes [58]. The role of Upc2 is also
conserved in C. parapsilosis (Guida et al, submitted). However,
conservation of sequence is not always indicative of conservation
of function. Our analysis suggests that the role of the CFEM family
in acquisition of iron from heme may be an ancient or ancestral
function. However, their role in biofilm formation may be
restricted to C. albicans, perhaps related to the formation of
hyphae in this species. There is also increasing evidence that
transcriptional rewiring is a major component of evolutionary
change [59]. For example, in C. albicans, the transcription factor
Cph1 is required for expression of the galactose pathway,
replacing the role of Gal4 in Saccharomyces species [60]. The role
of Mcm1 in regulation of mating and other genes differs
substantially between C. albicans and S. cerevisiae [61], and the
regulation of ribosomal protein expression is also significantly
different [62,63]. Whereas the Saccharomyces and Candida lineages
are fairly distant relatives [64], even within closely related species
there is considerable variation in transcription factor binding [65].
Our results suggest that there has been some rewiring of the Bcr1
regulon between the closely related species C. albicans and C.
parapsilosis, and that only regulation of the CFEM family is
conserved.
Materials and Methods
Ethics statement
All animal work was conducted with respect to the relevant
guidelines in Ireland and the American Association for Accred-
itation of Laboratory Care criteria. Ethical approval was obtained
from the Animal Research Ethics Subcommittee at University
College Dublin (P-08-55), and the Animal Research Committee of
the William S. Middleton Memorial Veterans Administration
Hospital (MV1947-0-01-11).
Strains and media
C. parapsilosis strains (Table S5) were routinely grown in YPD
medium (1% yeast extract, 2% peptone, 2% dextrose) at 30uC. To
determine the effect of reduced iron, a single colony was
inoculated in 5 ml of YPD overnight, and then diluted 5-fold in
YPD supplemented with 200 mg/ml of BPS. The culture was
incubated at 200 rpm for 5 h at 30uC, then washed and
resuspended in an equal volume of PBS. 5 ml was spotted on
YPD agar and where noted supplemented with 1 mM BPS or
2 mM Hemin (Fluka). Biofilms were developed on silicone squares
pre-treated with 10% FCS (fetal calf serum) in synthetic defined
(SD) medium supplemented with 50 mM glucose at 37uC. For
RNA extraction for the Bcr1 profiling experiment, cells were
grown in SD medium supplemented with 50 mM glucose and
10% FCS at 37uC. For plate tests, overnight cultures were diluted
5-fold in YPD supplemented with 200 mM BPS, and incubated for
5 h at 30uC. Cells were then washed three times with PBS buffer,
and resuspended in equal volume of PBS buffer. 5 ml of successive
dilutions of each cell culture was spotted on the agar plates. Agar
plates were incubated in the dark at 30uC for 14 days. All pictures
were taken on the same day and at the same magnification.
In vivo biofilm growth
Biofilms were developed in vivo using a rat central venous
catheter model, as described previously [35]. Catheters were
removed after 24 h. Sections were cut and examined using
Scanning Electron Microscopy (SEM).
Generation of gene knockouts
The sequences of oligonucleotide primers are listed in Table S5.
The generation of his1D/ura3D and bcr1D strains are described in
Figure S1.
CFEM2 and CFEM3 are adjacent genes in C. parapsilosis and
were disrupted simultaneously using URA3 and HIS1. Oligonu-
cleotides Cp25/26UH_F and Cp25/26UH_R were used to
amplify URA3 and HIS1, and the purified PCR products were
transformed into the CDUH3 strain by electroporation. CFEM2
and CFEM3 were then re-introduced separately into the double
mutant using the SAT1-flipper cassette. To reintegrate CFEM2,a
3.3 kb fragment including the entire CFEM2 ORF, 2.2 kb
upstream and 404 downstream sequence was amplified using
oligonucleotides Cp25/26_SacII and Cp25/26_SacI, and was
then cloned into plasmid pCD8 to generate pCD47. The upstream
sequence from CFEM3 was amplified using oligonucleotides
Cp25/26_KpnI and Cp25/26_ApaIRE, and the fragment was
cloned into plasmid pCD47 to generate pCD48. To reintegrate
CFEM3, the entire CFEM3 open reading frame (ORF) including
449 bp of upstream sequence and 378 bp of downstream sequence
was amplified using oligonucleotides Cp25/26_KpnI and Cp25/
26_ApaI, introducing restriction sites KpnI and ApaI, respectively.
The fragment was then cloned into plasmid pCD8 downstream
from the SAT1 cassette to generate pCD44. A 597 bp fragment
downstream from CFEM2 was amplified using oligonucleotides
Cp25/26_SacIIRE and Cp25/26_SacI, and cloned between
restriction sites SacI and SacII in pCD44 to generate pCD45.
Both plasmids pCD45 and pCD48 were linearized using
restriction enzymes PvuI and SacI, and the fragments were
transformed by electroporation. Strains harboring the correct
integrations were then manipulated to recycle the SAT1 cassette as
described previously by Ding and Butler [16].
CFEM6 was also disrupted using URA3 and HIS1. Oligonucle-
otides 2874UHF and 2874UHR were used to amplify URA3 or
HIS1 from plasmid pLUL2 and pLHL2, respectively. The PCR
products were purified and transformed into C. parapsilosis
CDUH3 by electroporation. We also knocked out CFEM6 using
the SAT1-flipper cassette. A 468 bp fragment, including 236 bp of
upstream sequence and 232 bp coding sequence from CFEM6,
was amplified using oligonucleotides 73/74Kpn2 and 73/74Apa,
which introduce restriction sites KpnI and ApaI. A 501 bp fragment
(39 to CFEM6) was amplified using oligonucleotides 73/74SII and
73/74SI, which introduce restriction sites SacII and SacI. Both
fragments were cloned between KpnI and ApaI sites, and SacII and
SacI sites respectively to generate plasmid pCD54. The KpnI/SacI
fragment was gel purified and transformed into the wildtype strain
(C. parapsilosis CLIB214) to knock out the first allele of CFEM6.T o
increase the efficiency of disruption of the second allele, a different
region was deleted using plasmid pCD55. A 486 bp fragment,
including 155 bp coding sequence and 331 bp downstream of
CFEM6 was amplified using oligonucleotides 74NSII and 74NSI,
introducing restriction sites SacII and SacI. This was then cloned
between SacII and SacI sites on pCD54 substituting the original
Bcr1 and CFEM Proteins in Candida Species
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then deleted as above.
Southern blots were carried out using DIG High Prime DNA
Labeling and Detection Starter Kit II (Roche). 20 mg of genomic
DNA from the wildtype and from the CFEM2/3 knockouts
(CLIB214, CDUH2526his, CDUH25/26, CD26, CD25, CD262,
and CD254) were digested with EcoRI/EcoRV. For CFEM2/
CFEM3, a probe was amplified using Cp25/26_KpnI and Cp25/
26_ApaIRE, which binds to a region of CFEM3 upstream from
the integration site. This detects a 4.18-kb fragment from the
wildtype allele, and a 3.5 kb fragment from replacement by URA3
or HIS1. Substitution of HIS1 with CFEM3 and the SAT1 cassette
generates a 4.3 kb fragment, which is reduced to 4.18 kb when the
cassette is removed. Substitution with CFEM2 and the SAT1
cassette generates a 3.27 kb fragment, which is reduced very
slightly (3.25 kb) when the cassette is removed.
To confirm the CFEM6 knockouts, genomic DNA was digested
with SacI. A probe was amplified from the 39 end of CFEM6 using
oligonucleotides2874probeFand 2874probeR.Thisdetects a 4.2-kb
fragment from the wildtype allele of CFEM6. A 2.9-kb fragment is
generated when URA3 and HIS1 are integrated at CFEM6.T h e
integration of either SAT1-flipper cassette at CFEM6 results a 5.9-kb
fragment. Recycling of the pCD54 construct results in a 1.9-kb
fragment, and recycling of pCD55 integration results a 1.7-kb
fragment.
DNA microarrays and RT-PCR
Cells were grown for 5 hours in SD medium supplemented with
50 mM glucose and 10% FCS at 37uC. RNA samples used in DNA
microarrays and RT-PCR were extracted using a Ribopure kit
(Ambion). The DNA microarrays were manufactured by Agilent
Technologies and represent 5,834 ORFs for C. parapsilosis and 6,101
ORFs for C. albicans [36,66]. cDNA synthesis and labeling were
carried out as described previously [36]. Seven biological replicates
were used for C. parapsilosis; in five the BCR1 knockout generated
using SAT1-flipper cassette samples (Cdb71) were labeled with Cy5,
and in two the knockout generated using URA3/HIS1 (CDUHB6)
were labeled with Cy3. Both knockouts were compared to the same
wildtype (CLIB214) labeled with Cy3 or Cy5 where appropriate.
Four biological replicates comparing C. albicans bcr1D and wild-type
strains (CJN702 and DAY286, from A. Mitchell) were also
examined by microarray, two of which were dye swaps.
cDNA hybridization, washing and scanning procedures were
carried out as described previously [36]. To determine the
transcriptional response of C. parapsilosis to low iron, overnight
cultures in YPD were diluted to an A600 of 0.2 in 100 ml SD
medium and the culture was incubated at 37uC for 5 h before
RNA extraction. In five replicates, two BPS treated samples were
labeled with Cy5, and three were labeled with Cy3 (dye swaps).
Two samples without BPS treatment were labeled with Cy3, and
three were dye swaps. Quantitative RT-PCR assays were carried
out as described previously [36].
Data analysis
Profiling experiments were carried out using C. albicans or C.
parapsilosis arrays manufactured with tools available from Agilent
eArray [36]. This microarray platform is described in the NCBI
Gene expression Omnibus Database (GEO) (GPL7693). Each
ORF is represented by two probes, both spotted in duplicate.
Data was analyzed was using the LIMMA package [67] from
the Bioconductor Project (http://bioconductor.org). The datasets
were preprocessed by applying Lowess normalization and no
background correction (as suggested in [68]). The duplicated
probes within each array were considered as technical replicates.
This assumption allows us to take full advantage of the platform
design, analyzing the within-array replicate spots using a pooled
correlation method. For the C. albicans and C. parapsilosis bcr1D
versus wildtype experiments, the final lists of differentially
expressed genes were generated by selecting probes with an
adjusted p-value less than 0.01, and a fold-change greater than 2
(Table S1 and Table S2). For the iron depletion study, the final list
of 149 genes was generated by selecting probes with a fold-change
greater than 1.5 and p-value lower than 0.05 (Table S3).
C. albicans orthologs were extracted from the Candida Gene
Order Browser [69], Maguire et al, in preparation. Raw
microarray data and the description of the array have been
deposited in the Gene Expression Omnibus database under the
accession number GSE33490, according to the MIAME guide-
lines.
5,214 C. parapsilosis orthologs of C. albicans genes were identified
(84.2% of the C. albicans genome). 83 of 149 genes differentially
expressed in the iron-depletion arrays have an ortholog in C.
albicans. All the GO term enrichment analysis were performed
using the web application ‘‘GO term finder’’ available on the
‘‘Candida Genome Database’’ (CGD, http://www.candidagen-
ome.org). The background for the test was appropriately adjusted
by excluding those C. albicans genes with no C. parapsilosis ortholog.
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